Table 3.

Outcomes of AML Patients With Late Leukemia Relapse

No. of AML Patients	Median Age [Years (Range)]	Median Duration of First CR1 [Years (Range)]	Patients (%) Achieving CR2	Survival	Ref.
15	48 (13–77)	9 (5.2–11.5)	86%	51%, 5-year OS probability	5
11	66 (37–79)	6.7 (5.5–11.4)	36%	6.4 months	6
9	64 (23–75)	6.1 (5.1–16.2)	66%	2.3 years	Current study